Making Waves in Pulmonary Hypertension: Is Sotatercept Changing the Current?: Mt. Sinai Hospital
At the Hospital or Via Zoom
Target Audience
All pharmacists
Learning Objectives
At the completion of this activity, the participant will be able to:
Review the pathophysiology of pulmonary arterial hypertension (PAH)
Summarize current guideline-directed management
Describe the mechanism of action of sotatercept and its role in therapy with available clinical evidence
Discuss a patient case to identify the role of sotatercept in therapy selection
Jane Cole PharmD
My name is Janie Cole and I am currently a PGY-1 pharmacy resident at The Mount Sinai Hospital. I earned my Doctor of Pharmacy degree from the Medical University of South Carolina in Charleston, SC. I will be continuing my training at Mount Sinai this July as a PGY-2 pharmacy resident in Critical Care, with a focus on further developing my clinical skills in the management of complex, critically ill patients.
0042-0000-26-014-L01-P
Available Credit
- 1.00 ACPEThe Arnold & Marie Schwartz College of Pharmacy and Health Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Facebook
X
LinkedIn
Forward